Agios Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
35.60
|
|
Average Rating
|
3.88
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.76
|
-1.49
|
0.27
|
15.34%
|
|
2022-06-30
|
-1.75
|
-1.68
|
0.07
|
4.00%
|
|
2022-03-31
|
-1.81
|
-1.74
|
0.07
|
3.87%
|
|
2021-12-31
|
-1.69
|
-1.74
|
-0.05
|
-2.96%
|
|
2021-09-30
|
-1.59
|
-1.56
|
0.03
|
1.89%
|
|
2021-06-30
|
-1.39
|
-1.41
|
-0.02
|
-1.44%
|
|
2021-03-31
|
-1.32
|
26.95
|
28.27
|
2141.67%
|
|
2020-12-31
|
-1.33
|
-1.41
|
-0.08
|
-6.02%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.91
|
|
2021-12-31
|
22.24
|
|
2020-12-31
|
-4.74
|
|
2019-12-31
|
-6.87
|
|
2018-12-31
|
-6.03
|
|
2017-12-31
|
-6.74
|
|
2016-12-31
|
-5.05
|
|
2015-12-31
|
-3.13
|
|
2014-12-31
|
-1.59
|
|
2013-12-31
|
-3.67
|